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ABSTRACT 
   
Greater than 11% of the total population of Americans age 12 and older were 
illicit drug users with close to 1 million suffering from cocaine use disorder in 2017 alone 
(SAMHSA, 2017), yet there are no effective pharmacological treatments for this disorder. 
Previous research from the Neisewander Laboratory in male rats found that 
administration of a 5-HT1BR agonist facilitates cocaine intake when given prior to a daily 
self-administration session, while inhibiting cocaine intake and attenuating drug-seeking 
behavior following 21 days of protracted abstinence, yet it is not known whether such 
effects are observed in female rats. Women face unique challenges in all phases of the 
drug addiction cycle. With respect to active drug-taking (i.e., the maintenance phase), 
women tend to increase their rate of consumption more rapidly than men, and female rats 
acquire cocaine self-administration faster than males. In part, this is due to ovarian 
hormone influences on the reinforcing properties of cocaine, where peak levels of 
endogenous estrogen hormones correspond to an increase in cocaine intake. In this study, 
we investigated the effects of CP94253, a selective 5HT1BR agonist, on cocaine intake 
across all phases of the estrous cycle in female rats. The rats were trained to self-
administer cocaine (0.75 mg/kg, IV) on a fixed ratio (FR) 5 schedule of reinforcement 
and daily vaginal smears were taken after each session to monitor the estrous cycle. Rats 
were pretreated with CP 94,253 (5.6 mg/kg, IP) or vehicle prior to separate tests during 
each estrous cycle phase and were then either given 1-h access to 0.75 mg/kg cocaine 
followed by 1-h access to 0.375 mg/kg cocaine or 1-h access to 0.1875 mg/kg cocaine 
followed by 1-h access to 0.075 mg/kg cocaine. Similar to males, CP 94,253 decreased 
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cocaine intake in females at intermediate doses, however, the estrous cycle phase did not 
alter this effect.  
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CHAPTER 1 
INTRODUCTION 
40 percent of drug abuse-related emergency department visits in 2011 involved 
cocaine (Drug Abuse Warning Network, DAWN) and despite substantial research 
investigating psychostimulant abuse, there are no effective, FDA-approved treatments for 
cocaine dependence. Though there are contrasting reports on the use of antidepressants for 
the treatment of cocaine dependence, it seems that they may be selectively effective in 
individuals comorbid with depression (Pollack & Rosenbaum, 1991; Batki, Manfredi, 
Jacob, & Jones, 1993; Pollack, Brotman, & Rosenbaum, 1989). Drugs that alter 5-HT 
neurotransmission were first recognized for their use in treating affective disorders, such 
as anxiety and depression (Grahame-Smith, 1989, 1992). However, affective and other 
psychiatric disorders are often comorbid with substance abuse, suggesting that these 
disorders may increase the risk of substance abuse (Regier, et al., 1990; Kessler, et al., 
1994).  Specifically, the evidence indicates that up to 56 percent of individuals diagnosed 
with an affective disorder had a co-occurring lifetime substance abuse. In some cases, 
treating affective disorders can diminish substance abuse and craving (Cornelius, 1997). 
There is strong clinical evidence that serotonin neurotransmission plays a role not only in 
affective disorders but also cocaine effects, suggesting a role in cocaine use disorders.  
The serotonergic system is complex as there are 14 receptor subtypes differentially 
distributed throughout the brain (Peroutka, 1995; Mohammad-Zadeh, Moses, & Gwaltney-
Brant, 2008). Among the 14 receptor subtypes are the 5-HT1B receptors (5-HT1BRs), which 
are located on the terminals of presynaptic neurons where they act to inhibit 
neurotransmitter release. 5-HT1BRs are autoreceptors on serotonergic neuron terminals 
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(Miszkiel, Filip, & Przegaliñski, 2011; Sharp, Bramwell, Hjorth, & Grahame-Smith, 1989; 
Hjorth & Tao, 1991) and heteroreceptors on non-serotonergic neuron terminals (Sari, 2004; 
Yan, Zheng, & Yan, 2004). Localization studies indicate that 5-HT1BR binding sites are 
highly concentrated in the mesocorticolimbic and nigrostriatal dopamine systems, which 
include the substantia nigra, nucleus accumbens, ventral tegmental area, and caudate 
putamen (Bonaventure, Langlois, & Leysen, 1998; Bonaventure, Schotte, Cras, & Leysen, 
1997; Varnas, Hall, Bonaventure, & Sedvall, 2001; Sari, 2004). These systems have been 
implicated in mediating the rewarding effects of cocaine (Sari, 2004).  
The 5-HT1BR is a potential target for novel pharmacological medications for 
cocaine abuse (Rocha, et al., 1998; Miszkiel, Filip, & Przegaliñski, 2011; Neisewander, 
Cheung, & Pentkowski, 2014). For example, 5-HT1BR knockout mice display a greater 
tendency to self-administer cocaine (Castanon, Scearce-Levie, Lucas, Rocha, & Hen, 
2000), and 5-HT1BR agonists decrease psychostimulant intake and seeking behavior after 
a period of abstinence in male rats (Neisewander et al., 2014; Garcia, Cotter, Leslie, Foster 
Olive, & Neisewander, 2017). Evidence from our lab suggests that in male rats that self-
administer cocaine, a switch in the effects of a 5-HT1BR agonist occurs as a result of 
abstinence. Prior to experiencing a prolonged abstinence period, pretreating male rats with 
the selective 5-HT1BR agonist, CP 94,253, prior to daily cocaine self-administration 
sessions produces a leftward shift in the dose-response curve, indicating an increase in the 
reinforcing value of cocaine. However, following 21 days of forced abstinence, CP 94,253 
decreases cocaine intake, flattening the inverted U-shaped dose-response curve 
(Pentkowski et al., 2014), suggesting attenuation of cocaine reinforcement. In addition, CP 
94,253 attenuates both cue-induced and cocaine-primed reinstatement of cocaine-seeking 
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behavior after daily extinction training during which the rats are abstinent (Pentkowski, 
Acosta, Browning, Hamilton, & Neisewander, 2009). These findings suggest that 5-HT1BR 
agonists attenuate motivation to seek cocaine. Collectively, this research suggests that 5-
HT1BR agonist may be useful in decreasing cocaine intake in males. 
Serotonergic neurotransmission, as well as 5-HT1BRs in particular, are affected by 
ovarian hormones. Early studies by Fludder and Tonge (1975) show that the concentration 
of the serotonin metabolite, 5-hydroxyindoleacetic acid (5-HIAA), significantly increases 
across brain regions during the proestrus phase when blood estrogen levels are highest, but 
decreases in all brain regions examined, except the hypothalamus, during the estrus phase 
when peak estrogen levels begin to decline. This same study revealed that serotonin 
concentration significantly decreases in the amygdala during proestrus and only decreases 
in areas such as the striatum and thalamus during estrus (Fludder & Tonge, 1975). These 
complex changes in serotonin during the estrous cycle may contribute to the effects of 5-
HT1BR agonists on cocaine self-administration. Later studies by Biegon and McEwen 
(1982) assessed how exogenous hormones, such as estradiol, modulate serotonin 1 
receptors in the brain. Their findings suggest that estradiol produces a biphasic effect on 
serotonin 1 receptor density in female rat brains. Specifically, estradiol pretreatment 
decreases serotonin 1 receptor density throughout the brain initially, followed by a selective 
increase in the hypothalamus, preoptic area, and amygdala 48-72 hours after initial 
estradiol pretreatment (Biegon & McEwen, 1982). The brain regions showing a selective 
increase in serotonin 1 receptor density are also areas known to be rich in estrogen receptors 
(Liu & Shi, 2015; Li, Blaustein, De Vries, & Wade, 1993; Yokosuka, Okamura, & Hayashi, 
1998). 
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To date, no experiments to our knowledge have investigated effects of 5-HT1BR 
agonists on cocaine self-administration and cocaine seeking in female rats. However, 
ovarian hormones are known to modulate the reinforcing properties of cocaine, suggesting 
that males and females may differ in their response to a treatment that is aimed at reducing 
drug intake (Carroll, Lynch, Roth, Morgan, & Cosgrove, 2004; Becker & Hu, 2008; Lynch, 
2006). Furthermore, in female rats, the response to test treatments may vary depending on 
the estrous cycle phase. In women, smoking cocaine during the follicular phase when 
estradiol level is elevated results in higher subjective ratings, such as higher self-
confidence, increased drug potency and a greater high compared to ratings during the luteal 
phase of the menstrual cycle (Sofuoglu, Dudish-Poulsen, Nelson, Pentel, & Hatsukami, 
1999; Evans, Haney, & Foltin, 2002). The higher subjective effects observed during the 
follicular phase are attenuated by the administration of progesterone (Evans & Foltin, 
2006). Additionally, women with high levels of progesterone display lower stress-induced 
and cue-induced cocaine craving when compared to women with lower levels of 
progesterone alone or in combination with estradiol (Sinha, et al., 2007). The progesterone 
metabolite, allopregnanolone, blocks the escalation of cocaine self-administration in rats 
(Anker, Zlebnik, & Carroll, 2010). These findings suggest that estradiol and progesterone 
have opposing effects on cocaine reinforcement in females.  
Cocaine self-administration studies with female rodents are generally consistent 
with the findings observed in women. Female rats acquire cocaine self-administration at a 
faster rate and consume a greater amount of cocaine than male rats (Lynch & Carroll, 
1999). Estrogen may play a role in this sex difference as the exogenous administration of 
estradiol increases the acquisition of cocaine self-administration in ovariectomized female 
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rats when compared to castrated male rats (Jackson, Robinson, & Becker, 2006) or 
ovariectomized vehicle control females and gonad-intact females receiving the estrogen 
antagonist, tamoxifen (Lynch, Roth, Mickelberg, & Carroll, 2001). These effects extend to 
other phases of the drug addiction cycle, such as maintenance of use and relapse. During 
the maintenance of daily cocaine self-administration, female rats in estrus display a 
preference for higher doses of cocaine compared to females in other phases (Lynch, Arizzi, 
& Carroll, 2000; Lynch, 2006). Additional research using the discrete trial procedure 
suggests that females escalate cocaine intake more than males. In this procedure, rats 
housed in operant self-administration chambers for 24 hours per day are given intermittent, 
discrete trials during which they have access to cocaine. Using this procedure, female rats 
take more cocaine over a 7-day period and display a greater initial binge period than males 
(Lynch & Taylor, 2004). Furthermore, administration of estradiol benzoate significantly 
increases binge length and the amount of cocaine self-administered (Lynch & Taylor, 
2005). Female rats tested on a progressive ratio (PR) schedule of reinforcement, which 
requires an exponential increase in the number of responses required to earn successive 
reinforcers, demonstrate higher breakpoints during estrus compared to other cycle phases.  
Breakpoint is the final schedule completed at which responding stops on the PR schedule, 
suggesting that motivation for cocaine is higher during the estrus phase (Roberts, Bennett, 
& Vickers, 1989; Hecht, Spear, & Spear, 1999).  
Other animal models of motivation for cocaine also suggest sex differences and the 
role of ovarian hormones in cocaine-seeking behavior. For example, Kippin and colleagues 
(2005) extinguished drug-seeking behavior of gonad-intact male and female rats trained to 
self-administer cocaine. They then found that females in estrus showed higher 
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reinstatement of drug-seeking behavior when primed with a high dose of cocaine compared 
to non-estrus females and males. The females’ sensitivity to the reinstatement of drug-
seeking behavior was further supported when female rats self-administered more saline 
than male rats after a cocaine-priming injection (Lynch & Carroll, 2000). Again, this sex 
difference may involve ovarian hormones as ovariectomized females given estradiol 
administration during the reinstatement test showed facilitated responding for cocaine 
compared to female rats treated with an oil control (Becker & Hu, 2008).  
Given that there are sex differences in acquisition, maintenance, and reinstatement 
of cocaine self-administration and cocaine-seeking behaviors with evidence that ovarian 
hormones are mediating these sex differences, it is important to examine both sexes when 
assessing potential pharmacological treatments for cocaine use disorders. I hypothesize 
that freely cycling female rats are more sensitive to the effects of the 5-HT1BR agonist CP 
94,253 on cocaine self-administration during the estrus and proestrus phases when blood 
estrogen levels are relatively higher and progesterone is low. I predict that CP 94,253 will 
produce a leftward shift in the dose-effect function in the estrus phase. We examined the 
effects of the 5-HT1BR agonist CP 94,253 on cocaine self-administration during the 
proestrus, estrus, metestrus, and diestrus stages of the estrous cycle using a fixed-ratio, low 
effort schedule of reinforcement. 
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CHAPTER 2 
METHODS 
Animals 
 Female Sprague-Dawley rats weighing 200-225 g arrived from Charles River 
(San Diego, CA) and were single-housed in a climate-controlled facility on a reversed 
light/dark cycle (10 h light/ 14 h dark cycle). Animals were handled for 1 week prior to 
any procedures. All rats had access to ad libitum food and water unless specified 
otherwise. Animal husbandry and experimental procedures were approved by the 
Institutional Animal Care and Use Committee at Arizona State University.  
Surgery 
 Rats underwent surgery to implant a chronic indwelling catheter into the jugular 
vein according to methods previously described (Pockros, Pentkowski, Swinford, & 
Neisewander, 2011). Briefly, rats were anesthetized with isoflurane (1-4%) and after 
implanting the catheter into the jugular vein, the opposite end which was attached to a 
metal cannula was anchored to the skull with dental acrylic cement. Rats were 
subsequently given 5-6 days of recovery before starting cocaine self-administration 
training. Catheters were flushed daily with 0.1 mL (i.v.) saline containing heparin sodium 
(70 USP/1 mL; SAGENT pharmaceuticals, Schaumburg, IL) and cefazolin (10 mg/0.1 
ml; WG Critical Care, LLC) to maintain patency and prevent infection. Also, catheters 
were periodically tested for patency by administering 0.05 mL methohexital sodium 
(Jones Pharma Inc) at a dose that produces anesthetic effects only when administered i.v. 
(16.7 mg/ml).   
Drugs 
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 Cocaine hydrochloride (RTI International, Research Triangle Park, NC) was 
dissolved in 0.9% bacteriostatic saline (Hospira Inc, Lake Forest, IL) and filtered through 
0.2 µm membrane Acrodisc syringe filters (PALL Corporation, Ann Arbor, MI). CP 
94,253 hydrochloride (5.6 mg/kg s.c.; Tocris Bioscience, MN) was made fresh daily and 
dissolved in 0.9% bacteriostatic saline. The volume of i.v. injections were 0.1 ml and all 
other injections were given at a volume of 1 ml/kg. 
Vaginal Swabs 
 As previously described by Byers et al. (2012), estrous cycle phases were 
determined by vaginal cytology. Rats were held firmly while a cotton-tipped swab 
(Puritan Medical Products Company, LLC, Guilford, ME) soaked in 0.9% bacteriostatic 
saline (Hospira Inc, Lake Forest, IL) was inserted into the vaginal opening and gently 
swiped in a circular motion. Cells were then transferred onto a glass slide and 
immediately viewed under a microscope (Nikon Eclipse E6000) at 10x magnification. A 
still image was captured and the stage of the estrous cycle was determined based on the 
presence or absence of different cell types as previously detailed (Marcondes, Bianchi, & 
Tanno, 2002) and shown in Figure 1. 
Apparatus 
 Operant conditioning chambers (30 x 25 x 25 cm3; Med Associates, St Albans, 
VT) were equipped with an active and inactive lever, a cue light above the active lever, a 
house light, and a tone generator mounted on the outside of the chamber near the active 
lever. Infusion pumps were located outside of a sound attenuating outer chamber. 
Polyethylene tubing attached to the drug syringe in the infusion pump entered through a 
port in the outer chamber wall and attached to liquid swivels (Instech, Plymouth, PA) 
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suspended above the operant conditioning chambers. The outlet line from the liquid 
swivel was encased inside a metal spring leash with a plastic connector that fastened to 
the cannula end of the catheter (PlasticsOne, Roanoke, VA) on top of the rats’ head. 
Self-Administration Training 
 Self-administration sessions occurred at the same time of day, 6 days per week for 
2 hours per session. Initially, rats were trained to self-administer 0.75 mg/kg/0.1 mL i.v. 
cocaine on a fixed ratio (FR) 1 schedule of reinforcement. Based on individual 
performance, rats progressed from an FR1 through an FR5. Schedule advancement 
automatically occurred once rats received at least 7 reinforcers within one hour during the 
session. To encourage exploration of operant chambers, rats were initially food restricted 
to 16 g of food/day three days prior to the first self-administration session and continuing 
until the FR5 schedule was achieved. In conjunction with advancing to the FR5, all rats 
were given ad libitum access to food. Daily vaginal swabs were conducted up to 1 hour 
before and 30 minutes after the sessions to track the estrous cycle phases. Testing began 
once rats displayed stable cocaine intake, defined as <15% variability in the number of 
infusions obtained across 3 consecutive sessions. 
Experimental Testing Procedure 
 Rats were tested for the effects of CP 94,253 on cocaine self-administration 
across metestrus, diestrus, proestrus and estrus cycle phases. We attempted to test each 
rat in each estrous cycle phase, however, because cocaine and the swabbing procedure 
appeared to interfere with normal estrous cycling, several rats did not complete all of the 
tests due to catheter failure. Furthermore, because cycle phase was not verified until after 
testing in order to avoid confounding effects of the swabbing procedure in close 
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approximation to the self-administration session, some rats were tested more than once 
under the same condition due to incorrect prediction of cycle phase, which was verified 
after the test. During each cycle phase, rats were tested twice, receiving pretreatment with 
vehicle (1 mL/kg, s.c) prior to one test and with CP 94,253 (5.6 mg/mL, s.c) prior to the 
other test.  Fifteen min after the pretreatment injection, rats were placed into the operant 
chambers for a 2-hour test session. The 5.6 mg/kg CP 94,253 (CP) dose used in this 
experiment was reported as the minimally effective dose capable of inducing changes in 
cocaine self-administration in male rats (Przegalinski, Gołda, Frankowska, Zaniewska, & 
Filip, 2008; Pentowski et al. 2009). Separate groups of rats were tested with 0.075 and 
0.1875 mg/kg, i.v. (low doses) cocaine available or with 0.375 and 0.75 mg/kg, i.v. (high 
doses) cocaine available. During a given test, the highest dose for each group was 
available first for one hour followed by the lower dose available for one hour. Rats were 
given a 5-minute time out in the home cage between the hour-long test intervals. 
Throughout testing, cocaine reinforcement was available on an FR5 schedule of 
reinforcement. To re-establish the stability criteria described above, rats were given at 
least 3 additional sessions between tests. 
Statistical Analysis 
 Statistical analyses were conducted with IBM SPSS Statistics 23.0. Infusions, 
active and inactive lever responses were analyzed as the dependent variables in separate 
ANOVAs with estrous cycle phase, cocaine dose, and CP 94,253 or vehicle pretreatment 
as between subjects’ factors. Although we had designed the experiment with CP 94253 
vs. vehicle pretreatment as a repeated measure, there was too much missing data to use 
the repeated measures ANOVA. The data from rats that had been tested multiple times 
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under the same condition due to mistaken predictions of estrous cycle phase were 
averaged and the average value was used in the ANOVA. Additionally, two-way 
ANOVAs with low dose/high dose groups and estrous cycle phase as between subjects’ 
factors were used to analyze effects of these variables on cocaine self-administration at 
the training dose prior to testing for effects of CP 94,253. Tukey post-hoc tests for 
multiple comparisons were used to identify the source of significant effects and 
interactions. All significant effects are reported and descriptive statistics are reported as 
the mean ± SEM. 
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CHAPTER 3 
RESULTS 
Cocaine self-administration during estrous cycle phases 
 Infusion rates, active and inactive lever responses, and cocaine intake once rats 
exhibited stable infusion rates on an FR5 schedule of reinforcement are shown for each 
cycle phase in Figure 2. There were no main effects of cycle phase for infusion rates, F(3, 
195) = 0.61, n.s. (Figure 2A), active lever responses, F(3, 195) = 0.87, n.s. (Figure 2C), 
or cocaine intake (Figure 2B), nor were there any interactions between estrous cycle 
phase and groups (i.e., high dose and low dose groups). However, there was a main effect 
of cocaine dose group for infusion rate, F(1, 195) = 36.22, p < 0.05, active lever 
responses, F(1, 195) = 42.53, p < 0.05, and cocaine intake, F(1, 205) = 38.57, p < 0.05, 
during these sessions. In each case, values were higher in rats who were tested at higher 
doses compared to rats who were tested at lower doses (Figure 2a-c). There were no 
effects of estrous cycle phase or differences between the high and low cocaine dose 
groups for inactive lever responses (Figure 2C).  Note, the group differences are not 
related to the cocaine test doses that establish the groups, but rather appear to be due to 
cohort differences as these groups were run at different times. 
Effects of CP 94,253 on cocaine self-administration during estrous cycle phases 
 Effects of pretreatment with CP 94,253 or vehicle on reinforcement rates across 
doses of cocaine during each estrous cycle phase are shown in Figure 3A-D. The 
ANOVA of infusions revealed a main effect of pretreatment, F(1, 357) = 6.40, p < 0.05 
(Figure 4A), indicating that CP 94,253 decreased cocaine infusions when compared to 
vehicle regardless of estrous cycle phase or dose of cocaine available. There was also a 
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main effect of cocaine dose group F(3, 357) = 23.48, p < 0.05 (Figure 4B). Post hoc 
comparisons showed that rats took fewer infusions when the higher 0.75 and 0.375 mg/kg 
doses were available compared to when the lower 0.075 and 0.1875 mg/kg cocaine doses 
were available (Tukey HSD, p < 0.05).  An interaction between pretreatment and cocaine 
dose, F(3, 357) = 3.70, p < 0.05, was observed (Figure 4C). Post hoc analysis showed that 
CP 94,253 decreased infusions at the middle 0.1875 and 0.375 mg/kg doses. There was 
no effect of estrous cycle phase on infusions nor were there interactions with the estrous 
cycle phase.  
 Cocaine intake (mg/kg, i.v.) across estrous cycle phases, cocaine doses, and 
pretreatments are shown in Figure 5A-D. Estrous cycle phase did not affect cocaine 
intake regardless of pretreatment or cocaine dose (Figure 5A-D) F(9, 358) = 1.29, n.s. 
Main effects of pretreatment, F(1, 358) = 7.13, p < 0.05 (Figure 5E), and cocaine dose, 
F(3, 358) = 132.59, p < 0.05 were observed (Figure 5F). CP94253 attenuated cocaine 
intake compared to the vehicle pretreatment (Figure 5E). Rats also showed a dose-
dependent increase in cocaine intake, where intake significantly increased at each 
successive dose of cocaine (Figure 5F) (Tukey HSD, p < 0.05).  
 Lever responses across cycle phases, cocaine doses, and pretreatments are shown 
in Figure 6A-D. Although there was no main effect of CP 94,253 versus vehicle 
pretreatment on active lever responses, F(3, 104) = 0.96, n.s., there was a main effect of 
cocaine dose, F(3, 104) = 8.99, p < 0.05 (Figure 6E), as well as an interaction between 
pretreatment and cocaine dose, F(3, 104) = 3.22, p < 0.05 (Figure 6F). Post hoc analysis 
of the cocaine dose main effect showed that rats made fewer responses at the 0.75 and 
0.375 mg/kg dose compared to both the 0.075 and 0.1875 mg/kg doses (Tukey HSD, p < 
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0.05). This pattern of effects was expected as the lower doses used are on the ascending 
limb of the typical inverted U-shaped dose-response curve for cocaine self-
administration. Post hoc analysis of the interaction between pretreatment and cocaine 
dose showed that response rate at the intermediate doses of cocaine (0.1875 and 0.375 
mg/kg) was attenuated after CP 94,253 pretreatment compared to vehicle pretreatment 
(Tukey HSD, p<0.05). The increase in response rate at the lowest dose of cocaine (0.075 
mg/kg) did not differ with CP 94,253 pretreatment compared to vehicle pretreatment. 
There was no effect of estrous cycle phase nor interactions with cycle phase.  There was 
also no significant main effects or interactions in the ANOVA of inactive lever responses. 
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CHAPTER 4 
DISCUSSION 
We hypothesized that freely cycling female rats would be more sensitive to the 
effects of the 5-HT1BR agonist on cocaine self-administration during the estrus and 
proestrus phases when blood estrogen levels are relatively higher and progesterone is low. 
First, we predicted that female rats will have higher cocaine intake during proestrus and 
estrus compared to all other phases of the estrous cycle. We also predict that CP 94,253 
will facilitate a more robust cocaine intake during estrus and proestrus phases of the estrus 
cycle. Surprisingly, the results did not support the hypothesis and predictions. Cocaine 
infusion rates, intake, or responses either prior to testing or during tests for CP 94,253 
effects were not different between estrous cycle phases, in contrast to previous research 
demonstrating increased intake during estrus (Becker & Hu, 2008). We previously reported 
that the selective 5-HT1BR agonist CP 94,253 (5.6 mg/kg, s.c.) enhanced cocaine infusion 
rates during the maintenance phase of self-administration in male rats (Pentkowski, et al., 
2014). The findings from this study indicated that CP 94,253 decreased cocaine intake and 
active lever response rates at moderate doses (Figure 4C, 6F). The CP 94,253-dependent 
decreases in cocaine self-administration observed at these particular doses of cocaine in 
female rats are the same as CP 94,253-dependent decreases observed in male rats. In our 
study in males, we observed a leftward shift in the dose-response curve after CP 94,253 
pretreatment, such that behavior when lower doses of cocaine were available appeared 
similar to the behavior of vehicle-pretreated controls when higher doses were available. 
Thus, we interpreted these findings as enhanced reinforcing value of cocaine not only based 
on this dose-response data on the FR5 schedule of reinforcement, but also the corroborative 
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findings of an increase in infusions on a high effort progressive ratio schedule. In the 
present study, we observed a nonsignificant increase in infusions (Figure 3A) and active 
lever presses (Figures 6A, 6F) at the lowest dose of cocaine, suggestive of a leftward shift 
in the dose-response function. However, we are unable to definitively conclude that CP 
94,253 produced a leftward shift in the FR5 dose-response function as these effects were 
not significant and we have no other data in female rats at this point to confirm a consistent 
pattern of changes indicative of enhancement in the value of cocaine reinforcement. The 
addition of a lower dose of cocaine on the ascending limb is needed because an increase in 
cocaine intake at a subthreshold dose after the administration of the 5-HT1BR agonist is 
one of the hallmarks of a leftward shift and this would show that female rats respond to 
cocaine self-administration in the same manner as male rats when CP 94,253 is on board.   
There is an apparent discrepancy between our findings and others implicating the 
role of estrogen in cocaine intake (Lynch & Taylor, 2004) and preference for higher doses 
of cocaine (Lynch, Arizzi, & Carroll, 2000) during the estrus phase in rats. Human studies 
parallel these findings with evidence suggesting that relative to the luteal phase of the 
menstrual cycle, women report more positive subject effects of psychostimulant use during 
the follicular phase when estradiol levels are high (Justice & De Wit, 2000; Justice & De 
Wit, 1999). The reason for the discrepancy is unclear, but may be related to the use of a 
low effort schedule in the present study because estrous cycle effects are more reliably 
observed under high effort schedules, such as the PR schedule (Lynch, 2006; Lynch & 
Carroll, 1999; Roberts drug-taking, 1989; Carroll, Morgan, Lynch, Campbell, & Dess, 
2002). For example, Roberts and colleagues (1989) studied how ovarian hormones 
influence the maintenance of cocaine self-administration on an FR1 schedule of 
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reinforcement, and found no hormonal effect. Under a PR schedule, these same researchers 
found that females obtained higher breakpoints during the estrus phase. These findings 
suggest that FR schedules may not be sensitive enough to detect changes in the estrous 
cycle-dependent motivation to self-administer cocaine. The PR schedule is likely more 
sensitive to the motivational effects of a drug because the work demand increases after 
each reinforcer obtained, whereas low effort FR schedules may result in ceiling effects 
(Lynch, Roth, & Carroll, 2002).  In addition, the relatively long duration of cocaine self-
administration prior to monitoring the estrous cycle in the present study may have a 
reduced sensitivity to detect estrous cycle effects. Consistent with this idea, chronic cocaine 
exposure disrupts the menstrual cycle in rhesus monkeys (Mello et al, 1997) and the estrous 
cycle in rats (King et al, 1990). After 18 days of cocaine self-administration, female rats 
often develop irregular cycles (Roberts et al, 1989) characterized by prolonged diestrus, 
multiple days of estrus, and an absence of proestrus (King et al, 1990).  
The estrous cycle did not appear to influence the effects of CP 94,253 on the cocaine 
dose-effect functions. The typical psychostimulant dose-effect function under low ratio 
schedules of reinforcement, such as an FR5, is an inverted U-shaped function 
(Neisewander et al, 2014; Pentowski et al, 2014; Garcia et al, 2017). As the dose increases 
within the low range of doses, intake and responses increase forming the ascending limb 
of the curve; however, at intermediate doses to high doses these measures decrease as inter-
infusion intervals increase with increases in cocaine dose, forming the descending limb of 
the curve. As described in Mello et al. (1986), a shift to the left of the dose-response 
function suggests that the treatment facilitates drug reinforcement, while a downward shift 
suggests attenuated drug reinforcement. Previous research in our laboratory, as well as 
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others, in male rats demonstrates that CP 94,253 shifts the dose-effect function for 
psychostimulant self-administration to the left (Pentowski et al, 2014; Parsons, Weiss, & 
Koob, 1996; Parsons, Weiss, & Koob, 1998; Garcia et al, 2017). It is possible that CP 
94,253 agonistic action on 5-HT1BRs has opposing effects across sexes, but as discussed 
above, it is difficult to definitively conclude how CP 94,253 altered the female dose-effect 
functions in this study, yet the effects observed at the intermediate cocaine doses did not 
interact with estrous cycle phase.   
The ability of ovarian hormones to regulate 5-HT1BRs may have played a role in 
the findings from this study. Biegon and McEwen (1982) showed that exogenous estradiol 
modulates 5-HT1 receptors (5-HT1R) in a biphasic manner in ovariectomized (OVX) rats. 
The initial decrease of 5-HT1R density observed in these OVX rats may be restricted to 
brain regions concentrated with estrogen receptors in the intact female rats that are freely 
cycling. Estrogen affects 5-HT receptor density but not affinity, suggesting that estradiol 
is not competing for the serotonin receptor but may cause regulatory changes (Biegon & 
McEwen, 1982). Considerable research has been devoted to investigating the mechanisms 
through which estrogen regulates the 5-HT transporter (SERT), 5-HT1A and 5-HT2A 
receptors, but not 5-HT1BR. We know that estrogen exert its effects on estrogen receptors 
(ERs) α and β, activating transcription factors for proteins that increase SERT (Hildebrandt, 
Alfano, Tricamo, & Pfaff, 2010). The activation of ERs deactivates 5-HT1ARs through the 
uncoupling of its G proteins (Mize & Alper, 2000; Mize & Alper, 2002; Mize, Poisner, & 
Alper, 2001), yet ER activation increases post-synaptic 5-HT2AR mRNA and amplifies 
sensitivity to pre-synaptic serotonin release (Sumner et al., 1999; Sumner et al., 2007). 
Estrogen is also known to down-regulate 5-HT1B autoreceptor mRNA in the dorsal raphe 
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nuclei (Hiroi & Neumaier, 2009). The mechanisms underlying estrogen effect on 5-HT1BR 
and its subsequent functional effects are still unclear. However, the evidence suggests that 
estrogen may down-regulate the density of 5-HT1BR, which may reduce the effect of CP 
94,253 on 5-HT1BR-mediated behavior. 
The mesocorticolimbic system is a major pathway through which 5-HT1BRs exert 
their influence on cocaine reinforcement. Sari (2004) have showed that 5-HT nerve fibers 
project to the mesocorticolimbic system, where they regulate dopaminergic projections 
from the ventral tegmental area (VTA) to the nucleus accumbens (NAc) (O’Dell, 
Manzardo, Polis, Stouffer, & Parsons, 2006; O’Dell & Parsons, 2004; Yan et al, 2004). In 
particular, potentiation of cocaine effects in male rats is thought to be due to 5-HT1B 
heteroreceptors on medium spiny GABAergic neurons in the VTA that inhibit GABA 
release, which results in the disinhibition of dopaminergic neurons (O’Dell et al., 2006; 
O’Dell and Parsons, 2004; Yan et al, 2004).  
It is important to mention that difficulty in identifying the estrous cycle phase 
resulted in repeated exposure to CP 94,253 in an aim to test during the desired cycle phase. 
We cannot rule out the possibility that our effects may have been dampened by tolerance 
from the repeated exposure to CP 94,253. This seems unlikely in light of Garcia et al. 
(2017) who found that repeated administration of the 5-HT1B/1A agonist zolmitriptan 
attenuated methamphetamine intake similarly across repeated injections.  Nonetheless, it 
is important to determine if chronic or multiple exposures to CP 94,253 results in the 
development of tolerance.  
This study followed a similar within-session design described previously with the 
exception of the testing order of cocaine doses (Pentowski et al., 2012; Pentowski et al., 
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2014). While Pentowski et al., (2012, 2014) tested cocaine doses in pseudorandom order, 
we tested cocaine doses in descending order in both groups (i.e., low vs. high dose groups). 
Studies have reported that ascending dosing schedule produces a greater condition place 
preference in mice, suggesting that the pattern of drug exposure can influence the 
magnitude of CPP (Conrad, Louderback, Milano, & Winder, 2013). Thereby, it is not far-
reaching to suggest that the pattern of our cocaine exposure may have had an impact on the 
magnitude of our dose-response function. Another limitation that may have complicated 
our findings were the cohort differences in cocaine intake prior to the 5-HT1BR agonist 
exposure.  
Cocaine dependence is a chronic relapsing disorder with evidence suggesting that 
5-HT1BRs are novel therapeutic targets for developing treatments for cocaine abuse. 
Previous research from our lab found that the 5-HT1BR agonist modulates cocaine abuse 
related-behavior depending on whether or not male rats have experienced a period of 
abstinence. Specifically, either viral overexpression of 5-HT1BRs or the administration of 
the 5-HT1BR agonist CP 94,253 facilitates cocaine intake during maintenance of self-
administration but attenuates cocaine intake after a period of abstinence (Pentowski et al., 
2009; Pentowski et al., 2014). Further research using lower doses of cocaine and higher 
schedules of cocaine reinforcement is needed to elucidate whether or not our results are 
due to a leftward shift at intermediate doses indicative of reinforcement enhancement or a 
true downward shift indicative of reinforcement attenuation during maintenance of 
cocaine self-administration in female rats. It is also necessary to determine if the 
administration of CP 94,253 will attenuate cocaine intake in female rats after a period of 
abstinence as observed in males. It is of utmost importance to examine whether the 
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abstinence-dependent switch in CP 94,253-induced attenuation of cocaine intake in male 
rats will persist after the resumption of cocaine self-administration. Therefore, it is 
important to test the effects of CP 94,253 on the resumption of cocaine self-
administration after a period of abstinence in male and female rats. 
 Lastly, I propose further testing using a behavioral economics paradigm as it is 
designed to provide a greater translational approach to the study of addiction-like behaviors 
in humans and animals (Cox et al., 2016). This paradigm is amenable to using a within-
session dose-response testing procedure, which would improve the efficiency of testing. 
The approach measures the demand for a drug and elasticity in its consumption. Demand 
(Q0), elasticity (α), and motivation to self-administer the reinforcer under varying unit 
prices (i.e., effort requirement) are estimated from the dose-response curve parameters 
(Bentzley, Fender, & Aston-Jones, 2013; Bentzley, Fender, & Aston-Jones, 2014). The 
variables measured above have been shown to predict addiction behaviors in humans 
(Petry, 2001; Gray & Mackillop, 2014; Murphy, Mackillop, Skidmore, & Pederson, 2009) 
and animals (Powell et al., 2019; Bentzley et al., 2013; Bentzley et al., 2014; Galuska, 
Banna, Willse, Yahyavi-Firouz-Abadi, & See, 2011). This would be an ideal model for 
translational purposes because it is modeled after behavioral economic procedures used to 
assess motivation for a drug in humans with existing drug dependence.  
In conclusion, this study showed that the selective 5-HT1BR agonist, CP 94,253, 
attenuates cocaine intake during maintenance of self-administration when intermediate 
doses of cocaine are available. Unfortunately, the limited number of doses of cocaine 
examined preclude drawing firm conclusions on whether the decrease in intake is due to 
enhancement or inhibition of cocaine reinforcing value due to the inverted U-shape of the 
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dose-response function. Evidence from human studies suggests that single nucleotides 
polymorphisms (SNPs) in the 5’ untranslated region of the HTR1b gene, which encodes 
the 5-HT1BR protein, is associated with drug dependence and psychiatric disorders 
(Proudnikov et al., 2006; Cao et al., 2011). These findings along with our study suggest 
that the 5-HT1BR may be a novel target for the development of therapeutics for the 
treatment of psychostimulant use disorders. 
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Figure 1. Representative photomicrographs of unstained vaginal smears from female rats 
in metestrus (A,), diestrus (B), proestrus (C) and estrus (D) phases of the estrous cycle. 
Cells were observed under a light microscope (Nikon Eclipse E6000) with a 40X 
objective lens. Estrous cycle phases were determined by the proportion of cell types 
observed in the vaginal cytology. Cornified cells (cc) are irregular shaped epithelial cells; 
regular epithelial cells (ec) are round and nucleated, and the smallest round cells are 
leukocytes (L). Metestrus is characterized by a mixture of all cell types (Figs. 1A). As the 
rodent transitions to diestrus, the predominant cell types are leukocytes and some 
cornified cells may still be present (Figs. 1B). Proestrus, the shortest phase of the cycle, 
will primarily consist of clusters of nucleated epithelial cells (cec) (Figs. 1C). The final 
phase is estrus, which is characterized by a predominance of cornified epithelial cells 
(Figs. 1D). 
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Figure 2. Lack of differences in cocaine self-administration across estrous cycle phases 
prior to CP94253 testing phase. Graphs represent mean (±SEM) number of infusions (A), 
mg/kg cocaine intake (B), and active and inactive lever responses (C) during the 
metestrus, diestrus, proestrus and estrus phases of the estrous cycle in animals tested with 
the low doses of cocaine available (0.075 and 0.1875 mg/kg, i.v.) or with the high doses 
of cocaine available (0.375 and 0.75 mg/kg, i.v.). Rats in both dosage groups were given 
access to 0.75 mg/kg/infusion cocaine on an FR5 schedule of reinforcement. There were 
no effects of estrous cycle phase for any of the measures, however, the high dose group 
(n = 20-24/cycle phase) had fewer cocaine infusions (a), active lever presses (b), and 
cocaine intake (c) when compared to the low dose group (n = 19-33/cycle phase). * 
indicates a significant difference between Low and High Dose groups (p < 0.05, Tukey 
HSD). 
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Figure 3. The effects of the 5-HT1BR agonist CP94253 on cocaine infusions during 
estrous cycle phases. The graphs display the mean (±SEM) number of cocaine infusions. 
Once infusion rates stabilized on an FR5 schedule, rats were pretreated with CP94253 or 
vehicle 15 minutes prior to the cocaine self-administration test session. Estrous cycle 
phases (A-D) did not influence infusion rates of rats pretreated with CP94253 or vehicle.  
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Figure 4. The effects of the 5-HT1BR agonist, CP94253, and dose of cocaine on the 
number of cocaine infusions obtained. The graphs display the mean (±SEM) number of 
cocaine infusions (A-C). Once infusion rates stabilized on an FR5 schedule, rats were 
tested after receiving pretreatment with CP94253 or vehicle 15 minutes prior to the 
cocaine self-administration test session. A main effect of pretreatment showed that 
CP94253 decreased cocaine intake regardless of cycle phase (A). A main effect of 
cocaine dose was also observed where rats consumed fewer infusions on higher doses 
compared to lower doses (B). When compared to vehicle, CP94253 decreased infusion 
rate at 0.1875 and 0.375 mg/kg cocaine doses (C). *p < 0.05, Tukey HSD.  In graph B, 
bars with different letters are different from each other, p < 0.05, Tukey HSD. 
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Figure 5. The effects of the 5-HT1BR agonist CP94253 on cocaine intake during the 
metestrus (A), diestrus (B), proestrus (C), and estrus (D) phases. Animals were pretreated 
with the 5-HT1B agonist CP94253 or vehicle 15 minutes prior to cocaine self-
administration tests. CP94253 pretreatment decreased cocaine intake when compared to 
vehicle (E), ANOVA main effect, p < 0.05. As doses increased, cocaine intake increased 
(F). In graph F, bars with different letters are different from each other, p < 0.05, Tukey 
HSD.   
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Figure 6. Active and inactive lever responses (mean ±SEM) during each phase of the 
estrous cycle (A-D) in rats pretreated with CP94253 or vehicle 15 minutes prior to 
cocaine self-administration tests on an FR5 schedule of reinforcement. Regardless of 
estrous cycle phase or CP94253 pretreatment, active lever responses dose-dependently 
decreased as cocaine dose increased (E); bars with different letters are different from 
each other, p < 0.05, Tukey HSD. Compared to vehicle, CP94253 decreased active lever 
responses at intermediate doses of cocaine (F). *difference from vehicle, Tukey HSD, 
p<0.05.  
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